Kód HS/KN 30021098 je pro přípravu na EUDR mimo oblast působnosti.
Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins) Indexovaný nástroj oblasti působnosti vrací pro tento kód výsledek Out of scope. No Annex I scope match was found for this indexed CN code.
Proč tato referenční stránka dává právě tuto odpověď.
- Popis kódu
- Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
- Základ v příloze I
- Bez přímé položky v příloze I
- Zdrojový základ
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Nadřazené, podřazené a sousední řádky.
Knihovní zobrazení slouží k referenční navigaci. Chcete-li spustit další kód jako akci, použijte kontrolu.
30farmaceutické výrobkyout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Co to znamená pro přípravu.
Tento řádek není v aktuálním výsledku oblasti působnosti přímým spouštěčem shromažďování dokladů.
Regulation (EU) 2023/1115 Annex I — relevant productsstaženo 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115staženo 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)staženo 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)staženo 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8staženo 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingstaženo 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersstaženo 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)staženo 2026-08-08